The Role of Glucagon-Like Peptide-1 Receptor Agonists in Cognitive Decline and Dementia Prevention: A Systematic Review and Semiquantitative Synthesis

Dementia, particularly Alzheimer’s disease (AD), is a major global health challenge with limited treatment options. Growing evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for type 2 diabetes mellitus (T2DM), may offer neuroprotective benefits by im...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Dharmendra Kumar Gupta, Arunima Chaudhuri
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wolters Kluwer Medknow Publications 2025-07-01
Saila:	Journal of Mental Health and Human Behaviour
Gaiak:	alzheimer’s disease cognitive decline dementia prevention glucagon-like peptide-1 receptor agonists neuroprotection type 2 diabetes mellitus
Sarrera elektronikoa:	https://journals.lww.com/10.4103/jmhhb.jmhhb_71_25
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!